– GEN’s Editor-in-Chief, John Sterling, interviews Dr. Robert Nagourney, Medical and Laboratory Director at Rational Therapeutics, about individualizing cancer therapies for patients.

Previous articleCrohn’s Disease Closer to being Added to Tysabri’s Label
Next articleAndroBioSys Licenses Technology from Roswell Park Cancer Institute to Improve Prostate Cancer Treatment